From: 7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
AJC*
LOM**
PaPâ€
CHAQ DI‡
PhDAâ€
Baseline
17
14
49
1.05
57
Improvement at Week 56 of OLE
90%
70%
74%
83%
84%